What is ControlRad?
Founded and headquartered in Norcross, Georgia, ControlRad develops solutions designed to mitigate the lifetime risk of radiation exposure from fixed and mobile C-arm procedures. Their technology aims to protect both patients and healthcare professionals from unnecessary radiation, a critical concern in interventional radiology and other medical imaging fields. The company's focus on safety and risk reduction positions it within the growing medical technology sector, particularly in areas requiring advanced imaging and precise radiation management.
How much funding has ControlRad raised?
ControlRad has raised a total of $22M across 3 funding rounds:
Series A
$3M
Series B
$15M
Debt
$4M
Series A (2017): $3M, investors not publicly disclosed
Series B (2019): $15M led by Questa Capital
Debt (2020): $4M supported by SVB Financial Group
Key Investors in ControlRad
SVB Financial Group
SVB Financial Group, a financial services provider founded in 1983, offers a comprehensive suite of banking and investment services, likely supporting technology and healthcare ventures.
Questa Capital
Questa Capital is a venture capital firm specializing in innovative healthcare companies that aim to enhance patient experiences and reduce costs, investing in next-generation healthcare solutions.
What's next for ControlRad?
The recent major strategic investment and the overall enterprise-level funding indicate a strong growth trajectory for ControlRad. This capital infusion is likely to fuel further development of their radiation reduction technologies, expansion into new markets, and strengthening of strategic partnerships within the healthcare ecosystem. ControlRad appears poised to enhance its market presence and continue its mission of improving safety standards in medical imaging.
See full ControlRad company page
